Hilary Tamara Wolf, MD in Baltimore, MD - Medicare Pediatrics

Hilary Tamara Wolf, MD is a medicare enrolled "Pediatrics - Adolescent Medicine" physician in Baltimore, Maryland. Her current practice location is 22 S Greene St, Baltimore, Maryland. You can reach out to her office (for appointments etc.) via phone at (410) 328-7373.

Hilary Tamara Wolf is licensed to practice in Maryland (license number D84111) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1003077645.

Contact Information

	Hilary Tamara Wolf, MD
	22 S Greene St, Baltimore, MD 21201-1544
	(410) 328-7373
	(410) 328-7305

Physician's Profile

Full Name	Hilary Tamara Wolf
Gender	Female
Speciality	Pediatrics - Adolescent Medicine
Location	22 S Greene St, Baltimore, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1003077645
Provider Enumeration Date: 06/17/2008
Last Update Date: 07/21/2022

Medicare PECOS Information:

PECOS PAC ID: 0244464238
Enrollment ID: I20171026001055

Medical Identifiers

Medical identifiers for Hilary Tamara Wolf such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003077645	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080A0000X	Pediatrics - Adolescent Medicine	MD041745 (District Of Columbia)	Secondary
2080A0000X	Pediatrics - Adolescent Medicine	D84111 (Maryland)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hilary Tamara Wolf allows following entities to bill medicare on her behalf.

Entity Name	University Of Maryland Pediatric Associates, Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1528163912 PECOS PAC ID: 6800888678 Enrollment ID: O20040401000195

News Archive

Angioplasty and stenting for renal artery lesions

The largest-ever randomized study to evaluate the effectiveness of catheter-based interventions in patients with narrowing of the renal artery has shown that angioplasty and stenting offer no benefit over medical therapy.

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature.

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

More forms of mercury can be converted to deadly methylmercury than previously thought, according to a study published Sunday in Nature Geoscience. The discovery provides scientists with another piece of the mercury puzzle, bringing them one step closer to understanding the challenges associated with mercury cleanup.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hilary Tamara Wolf is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Hilary Tamara Wolf, MD Po Box 62063, Baltimore, MD 21264-2063 Ph: (410) 706-5181	Hilary Tamara Wolf, MD 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 328-7373

News Archive

Angioplasty and stenting for renal artery lesions

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

Pediatrics Doctors in Baltimore, MD

Dr. Carmel Bogle, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 443-287-0526 Fax: 410-955-0897
Anna Eunjoo Choe, Pediatrics Medicare: Medicare Enrolled Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205 Phone: 410-955-3362 Fax: 410-614-1582
Dr. Melissa Lauren Shapiro, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215 Phone: 410-601-8663
Dr. Alexander James Jaksic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 781-223-0948
Adam J Spanier, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 300 Armory Pl, Baltimore, MD 21201 Phone: 410-225-8780 Fax: 410-225-8766
Milagritos D Tapia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-6749 Fax: 410-328-6136

Hilary Tamara Wolf, MD - Medicare Pediatrics in Baltimore, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Angioplasty and stenting for renal artery lesions

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Angioplasty and stenting for renal artery lesions

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Positive results from NanoString's second clinical study of PAM50-based breast cancer assay

Discovery brings scientists one step closer to understanding challenges linked to mercury cleanup

Pediatrics Doctors in Baltimore, MD